Roche to buy LumiraDx’s technology platform for US$ 295 million
Roche will pay a purchase price of USD 295 million and an additional payment of up to USD 55 million
Roche will pay a purchase price of USD 295 million and an additional payment of up to USD 55 million
BioVaxys has been granted exclusivity while the parties work in good faith on the drafting of a definitive agreement
Reinforces Henkel commitment to supporting customers and ecosystem in medical healthcare
CureVac is among many pharmaceutical companies looking to produce a novel seasonal influenza vaccine via mRNA technology
The non-enzymatic electrochemical sensing strip can simultaneously detect the direct and total bilirubin in a single drop of blood, and provide the concentrations within a minute
The medical device sector is considered as one of the sunrise sectors in the country
DeltaV control system natively integrated into Sartorius Biostat STR bioreactors provide a foundation for semi-autonomous operations and up to 80% less integration time
The primary purpose of this collaboration is to bring the optimized protein into the Indian market
PEEK brings a new quality to dental care for patients
        Subscribe To Our Newsletter & Stay Updated